Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy

NCT01018758 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-Induced Nausea and Vomiting
Non Hodgkin's Lymphoma

Interventions

DRUG: Palonosetron

Sponsor

Gruppo Italiano Studio Linfomi